The role of artificial intelligence in hypertensive disorders of pregnancy: towards personalized healthcare.

Journal: Expert review of cardiovascular therapy
PMID: 37300317

Abstract

INTRODUCTION: Guidelines advise ongoing follow-up of patients after hypertensive disorders of pregnancy (HDP) to assess cardiovascular risk and manage future patient-specific pregnancy conditions. However, there are limited tools available to monitor patients, with those available tending to be simple risk assessments that lack personalization. A promising approach could be the emerging artificial intelligence (AI)-based techniques, developed from big patient datasets to provide personalized recommendations for preventive advice.

Authors

  • Mohanad Alkhodari
    Cardiovascular Clinical Research Facility, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Zhaohan Xiong
    Auckland Bioengineering Institute, The University of Auckland, Auckland, 1142, New Zealand.
  • Ahsan H Khandoker
    Department of Biomedical Engineering, Khalifa University, Abu Dhabi, United Arab Emirates.
  • Leontios J Hadjileontiadis
    Department of Electrical and Computer Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Paul Leeson
    Ultromics Ltd, Oxford, United Kingdom.
  • Winok Lapidaire
    Cardiovascular Clinical Research Facility, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Keywords

External Resources

Popular Topics
Recent Journals